DB3 - THE IMPLICATIONS OF USING A 30-, 60-, OR 90-DAY GAP IN TREATMENT TO SPECIFY LINES OF CARE IN GASTRIC CANCER TREATMENT
| Autor: | Seal, B, Shermock, KM, Asche, CV, Kreilick, C, Xia, F, Kish, J, Zagadailov, EA, Eaddy, M |
|---|---|
| Zdroj: | In Value in Health May 2015 18(3):A2-A2 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect